RY 172.7 -0.1792% SHOP 152.38 -3.7762% TD 74.49 -0.4144% ENB 58.66 0.2906% BN 80.21 0.2124% TRI 235.76 -0.7034% CNQ 42.27 -1.3305% CP 102.81 -2.4851% CNR 145.02 -0.9426% BMO 139.15 0.5855% BNS 77.045 -0.149% CSU 4497.2998 0.6756% CM 92.23 -0.335% MFC 43.28 0.8858% ATD 79.0 -1.1882% NGT 53.35 -1.8038% TRP 65.26 0.215% SU 49.61 -1.411% WCN 251.65 -0.2181% L 191.14 0.1205%

Nanalysis Scientific Corp

Technology CA NSCI

0.305CAD
-(-%)

Last update at 2024-12-19T16:54:00Z

Day Range

0.300.31
LowHigh

52 Week Range

0.330.60
LowHigh

Fundamentals

  • Previous Close 0.30
  • Market Cap40.70M
  • Volume18651
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.08300M
  • Revenue TTM39.47M
  • Revenue Per Share TTM0.38
  • Gross Profit TTM 10.24M
  • Diluted EPS TTM-0.12

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -10.39900M -1.77200M -3.97500M -1.39900M 0.14M
Minority interest - - - - -
Net income -9.91500M -1.77200M -3.67800M -1.66000M 0.07M
Selling general administrative 15.02M 8.28M 6.75M 5.22M 4.77M
Selling and marketing expenses - - - - -
Gross profit 11.14M 10.24M 5.17M 6.06M 5.40M
Reconciled depreciation 4.65M 2.57M 1.77M 0.84M 0.37M
Ebit - -1.19100M -3.74100M 0.06M 0.29M
Ebitda -5.26100M 1.38M -1.97100M 0.91M 0.66M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -9.91000M -1.19100M -3.74100M 0.07M 0.29M
Other operating expenses - - - - -
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision -0.48400M 0.00000M -0.29700M 0.26M 0.06M
Interest income - 0.00200M 0.33M - -
Net interest income -0.07600M 0.00200M 0.33M 0.06M -0.11700M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - -0.29700M 0.26M 0.06M
Total revenue 24.82M 16.04M 7.87M 8.36M 8.38M
Total operating expenses 34.73M 17.23M 11.62M 8.30M 8.09M
Cost of revenue 13.68M 5.80M 2.71M 2.30M 2.98M
Total other income expense net -0.41300M -0.58300M -0.56200M -1.52400M -0.03500M
Discontinued operations - - - - -
Net income from continuing ops -9.91500M -1.77200M -3.67800M -1.66000M 0.07M
Net income applicable to common shares - -1.77200M -3.67800M -1.66000M 0.07M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 53.82M 69.90M 37.79M 23.99M 18.31M
Intangible assets 15.95M 26.63M 14.11M 12.69M 6.49M
Earning assets - - - - -
Other current assets 1.60M 2.06M - - -
Total liab 30.34M 22.33M 13.83M 9.64M 3.19M
Total stockholder equity 23.48M 35.13M 23.96M 14.34M 15.12M
Deferred long term liab - - 12.48M 12.09M 5.91M
Other current liab 0.43M 0.81M 2.01M 2.58M 0.70M
Common stock - - 31.30M 20.66M 18.27M
Capital stock 53.20M 49.02M 31.30M 20.66M 18.27M
Retained earnings -34.98900M -18.79300M -9.69200M -7.92000M -4.24200M
Other liab - - 1.40M 0.67M 0.30M
Good will 5.70M 13.08M 0.39M - -
Other assets - - 12.48M 12.09M 5.93M
Cash 0.76M 3.52M 10.40M 3.16M 6.62M
Cash and equivalents - - - - -
Total current liabilities 14.60M 13.51M 8.65M 5.63M 1.63M
Current deferred revenue - - - - -
Net debt 18.29M 3.92M - - -
Short term debt - - - - -
Short long term debt 6.49M 3.65M 1.94M 0.21M 0.12M
Short long term debt total - - - - -
Other stockholder equity - - 0.71M 0.21M -
Property plant equipment - - 2.54M 1.95M 1.63M
Total current assets 17.91M 21.95M 20.76M 9.35M 10.16M
Long term investments 5.73M - - - -
Net tangible assets - - 21.95M 13.75M 14.54M
Short term investments - - - - -
Net receivables 8.33M 6.08M 6.10M 3.04M 2.56M
Long term debt 12.56M 3.79M 2.75M 2.81M 1.02M
Inventory 5.79M 7.39M 3.68M 2.83M 0.86M
Accounts payable 5.08M 5.76M 4.44M 2.62M 0.68M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 3.11M 0.94M - - -
Deferred long term asset charges - - - - -
Non current assets total 35.91M 47.95M 17.03M 14.64M 8.14M
Capital lease obligations 2.92M 3.31M 1.30M 0.75M 0.37M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -11.73100M -3.34700M -4.11000M -3.13900M -2.24800M
Change to liabilities - 0.00000M 0.00000M 0.00000M 0.08M
Total cashflows from investing activities - -3.34700M -4.11000M -3.13900M -2.24800M
Net borrowings - 1.17M 1.03M 0.08M -0.14400M
Total cash from financing activities 13.21M 11.79M 1.27M 8.20M 2.09M
Change to operating activities - -2.56300M 1.28M 1.05M -0.94100M
Net income -9.91500M -1.77200M -3.67800M -1.66000M 0.07M
Change in cash -6.88000M 7.25M -3.46100M 5.84M -0.32600M
Begin period cash flow 10.40M 3.16M 6.62M 0.78M 1.10M
End period cash flow 3.52M 10.40M 3.16M 6.62M 0.78M
Total cash from operating activities -8.35500M -1.19900M -0.62300M 0.78M -0.17100M
Issuance of capital stock - - - - -
Depreciation 4.65M 0.86M 0.79M 0.55M 0.20M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M - - - -
Change to inventory - - - - -0.06254M
Change to account receivables - - - - -1.32449M
Sale purchase of stock - - - - -
Other cashflows from financing activities - 0.00200M 0.00200M 1.49M 1.49M
Change to netincome - 0.57M 0.00600M 0.55M 0.32M
Capital expenditures 7.20M 0.59M 0.43M 0.55M 0.80M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -4.87700M -2.56300M 1.28M 1.05M -0.94100M
Stock based compensation 1.56M 0.59M 0.42M 0.39M -
Other non cash items 0.15M -0.02200M -0.11300M -0.10200M -0.02900M
Free cash flow -15.55600M -4.20300M -3.52400M -2.35800M -2.41900M

Peer Comparison

Sector: Technology Industry: Scientific & Technical Instruments

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NSCI
Nanalysis Scientific Corp
- -% 0.30 - 21.74 1.03 1.68 1.44 -31.0169
PNG
Kraken Robotics Inc
0.06 2.46% 2.50 47.80 33.56 6.82 11.73 7.20 40.16
EDY
Eddy Smart Home Solutions Ltd
0.10 4.65% 2.25 - - 5.36 0.79 5.00 -2.1406
JTC
JEMTEC Inc
- -% 0.91 40.50 - 1.43 0.96 0.35 1.67

Reports Covered

Stock Research & News

Profile

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60 MHz and 100 MHz NMR platform; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides and software products, such as NMRGui, which is an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform, that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; and installation and maintenance services of commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.

Nanalysis Scientific Corp

Bay 1, 4600 5th Street NE, Calgary, AB, Canada, T2E 7C3

Key Executives

Name Title Year Born
Mr. Martin Andrew Burian CPA, CA, CPA Corp. Sec. & Independent Chairman 1964
Mr. Sean Krakiwsky M.Sc. Founder, CEO, Pres & Director 1970
Mr. Julien Muller Chief Technology Officer NA
Mr. Randall McRae C.A., CPA Corp. Controller & Interim CFO NA
Dr. Heather Phillips Director of Operations NA
Mr. Matthew Selinger Investor Relations Mang. NA
Dr. Matt Zamora Sales Mang. NA
Dr. Susanne Riegel Director of Marketing & Product Mang. NA
Dr. Greg McFeetors Head of Manufacturing NA
Mr. Sean Krakiwsky M.Sc. Founder, CEO, President & Director 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.